Spagnol succeeds Patrick Glaser, who has decided to return to the USA after three years leading Novasep in France.
Spagnol joins Novasep from pharmaceutical company Shasun, where he was president and chief technology officer.
Roger-Marc Nicoud, founder and non-executive chairman of Novasep, said: “We are delighted to welcome Michel Spagnol to Novasep as CEO. His track record in delivering customer driven solutions, his international and scientific background coupled with his extensive management experience, longstanding knowledge and relationships in the pharmaceutical industry will be strong assets for the company. He has all the qualities required to consolidate and accelerate Novasep’s development.”
